Massive postoperative pulmonary embolism in a young woman using oral contraceptives: the value of a preoperative anesthetic consult by Amar, Sarah et al.
Available at:
http://hdl.handle.net/2078.1/161356
[Downloaded 2019/04/19 at 05:11:56 ]
"Massive postoperative pulmonary embolism
in a young woman using oral contraceptives:
the value of a preoperative anesthetic consult"
Amar, Sarah ; Van Boven, Michel ; Rooijakkers, Herbert ; Momeni, Mona
Abstract
We describe the case of a woman with a history of active tabagism and on the oral
contraceptive Yasmin, presenting in the Post-Anesthesia Care Unit (PACU) with
a cardiac arrest due to massive pulmonary embolism following transforaminal
lumbar interbody fusion surgery. The patient had preoperatively several risk
factors for deep venous thrombosis. This case-report emphasizes the value of
a preoperative anesthetic visit and eventual temporary cessation of certain oral
contraceptives in specific cases.
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Abstract : We describe the case of a young woman with a history of active tabagism and on 
oral contraceptive Yasmin®, presenting in the Post-Anesthesia Care Unit (PACU) a cardiac 
arrest due to a massive pulmonary embolism following a Transforaminal Lumbar Interbody 
Fusion surgery. The patient showed preoperatively several risk factors of a deep venous 
thrombosis. 
This case-report and other similar publications in the literature emphasize the value of 
preoperative anesthetic visit and eventual quitting of certain oral contraceptives in specific 
cases. 
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CLINICAL CASE  
A young 45-years old woman with a history of hypothyroidism, overweight (BMI 27.9 kg/m² 
with 75 kg for 164 cm) and active tabagism (20-60 cigarettes per week) presents at the 
neurosurgery consultation for incapacitating lumbar radicular pain. The lumbosacral spine 
tomodensitometry shows severe spinal L5-S1 and right foraminal L4-L5 stenosis and 
moderate left L4-L5 stenosis, due to a bilateral spondylolysis L4 and L5, an anterolisthesis L5 
grade III and L4 grade I. In agreement with the patient and due to her functional limitation, 
the decision to perform a Transforaminal Lumbar Interbody Fusion has been made. 
At the preoperative anesthetic visit, 8 days before the surgery, the patient complained of 
bilateral sciatic pain with normal leg flexibility. She had no other symptoms. She was on a 
thiazide diuretic, and on a combined oral contraceptive Yasmin® containing Ethinyloestradiol 
and Drospirenone. The cardiopulmonary examination revealed normal. No preoperative 
coagulation testing was realized as she showed normal values two years previously. 
Upon arrival in the operating room, the patient is wearing compression stockings. The 
intervention takes place in the prone position. The surgery lasts more than 8 hours and is 
uneventful. At the end of the procedure, the patient is turned back into the supine position and 
extubated without any problems. 
Six minutes upon arrival in the PACU, the patient shows a cardiac arrest. The 
cardiopulmonary resuscitation starts immediately, with a no-flow time equal to 0, 
uninterrupted chest compressions, endotracheal intubation, as well as arterial line and central 
venous catheter insertion. Return of spontaneous circulation is observed with a low-flow time 
equal to 25 minutes. However, the patient becomes very unstable, and despite vascular filling, 
a total dose of 10 mg of adrenaline and external cardiac massage, no effective circulation can 
be restored. A transesophageal echocardiography is then realized, showing a massive 
thrombus invading the right atrium and right ventricule. 
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The patient is transferred to the cardiac surgery operating room and cardiopulmonary bypass 
is initiated 76 minutes after the initial cardiac arrest. The thrombus is surgically removed. 
After the completion of the surgery and due to the impossibility to wean off cardiopulmonary 
bypass, the patient is put on a femoro-femoral extracorporeal life support. At this moment the 
patient shows clinical and biological signs of a disseminated intravascular coagulation, and 
necessitates massive transfusion and a neurosurgical revision for hemostasis in the left lateral 
decubitus. 
During the cardiac surgery, the bilateral electroencephalogram (EEG) obtained by the cerebral 
monitor NeuroSense® remains isoelectric during 1 hour. 
In the postoperative period an EEG and somesthetic evoked potentials are performed, 
showing absence of any cortical activity. In agreement with the family, the extracorporeal life 
support is stopped and a comfort care is established. The patient dies on the third 
postoperative day. 
 
DISCUSSION  
The occurrence of deep venous thrombosis has been associated with the consumption of 
combined oral contraceptive (1, 2, 3). The risk is even increased in the presence of other risk 
factors such as tabagism, obesity, coagulation abnormalities, family history, hypothyroidism 
(4, 5)… 
In this regard, the oral Ethinyloestradiol and Drospirenone containing contraceptive Yasmin® 
has been the subject of several publications, suggesting an increased risk of deep venous 
thrombosis (6, 7, 8, 9) and pulmonary embolism (8, 10, 11, 12). 
Moreover, its combination with tobacco consumption seems devastating (4). 
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However, other studies could not show any significant difference between oral contraceptives 
with or without Drospirenone with regard to the occurrence of deep venous thrombosis (13, 
14, 15, 16). 
Our patient suffered since several months from bilateral sciatic pain and was therefore limited 
in her daily physical activities. 
Considering the huge thrombus discovered by the transesophageal echocardiography, it is 
more than plausible that she suffered from deep venous thrombosis before the start of the 
surgery. In the presence of active smoking, chronic Yasmin® intake, and a very limited 
physical activity, a preoperative doppler ultrasonography of the legs would have detected a 
deep venous thrombosis. On the other hand, discontinuation of the oral contraceptive and if 
possible smoking should have been discussed with the patient at the moment of the 
preoperative visit. These points are especially true in face of the type of surgery she was going 
to undergo. 
 
CONCLUSION  
This case-report emphasizes the value of preoperative anesthetic visit. In patients at high risk 
of deep venous thrombosis and undergoing major surgery, the discontinuation of oral 
contraceptives should be considered. A doppler ultrasonography can be justified to exclude 
the presence of a preoperative deep venous thrombosis. 
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